Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,029 | -28,208 | -21,557 | -14,359 | -14,240 |
| Depreciation Amortization | 110 | 1,057 | 763 | 469 | 228 |
| Accounts receivable | N/A | N/A | N/A | N/A | 806 |
| Accounts payable and accrued liabilities | 1,385 | 1,125 | 1,407 | 1,759 | -1,323 |
| Other Working Capital | -678 | -150 | 1,712 | 1,742 | -1,624 |
| Other Operating Activity | -927 | 3,997 | 2,772 | 872 | 500 |
| Operating Cash Flow | $-8,139 | $-22,179 | $-14,903 | $-9,517 | $-15,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -654 | -559 | -559 | N/A |
| Investing Cash Flow | $-17 | $-654 | $-559 | $-559 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -14 |
| Common Stock Issued | 40 | 82 | 17 | 78 | N/A |
| Other Financing Activity | 0 | 21,120 | 10,009 | 1,169 | 0 |
| Financing Cash Flow | $10,040 | $21,202 | $10,026 | $1,247 | $-14 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -87 |
| Beginning Cash Position | 8,414 | 10,045 | 10,045 | 10,045 | 88,756 |
| End Cash Position | 10,298 | 8,414 | 4,609 | 1,216 | 73,002 |
| Net Cash Flow | $1,884 | $-1,631 | $-5,436 | $-8,829 | $-15,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,139 | -22,179 | -14,903 | -9,517 | -15,653 |
| Capital Expenditure | -17 | -654 | -559 | -559 | N/A |
| Free Cash Flow | -8,156 | -22,833 | -15,462 | -10,076 | -15,653 |